Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
PRPureTech Health plc logo

PureTech Health plc (PRTC)

NASDAQ · Currency in USD
$17.38 ▲ +0.36 (+2.12%)
At close: Jul 17, 9:30 AM ET. Market closed.

Summary

Previous Close
$17.02
Open
$16.87
Day's Range
$16.87 – $17.38
52 Week Range
$14.50 – $19.92
Volume
9,859
Avg. Volume
9,189
Market Cap
$4.23B
Beta (5Y Monthly)
0.76
PE Ratio (TTM)
--
EPS (TTM)
-$45.37
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$57.00

Profile: PureTech Health plc

Sector
Healthcare
Industry
Biotechnology
Full-time employees
56
CEO
Robert William Henry Lyne

PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms.

Earnings

DateEst.Actual
Apr 29, 2026-$1.94-$26.90Miss
Aug 28, 2025-$2.04-$1.90Beat
Apr 30, 2025-$2.83$3.60Beat
Aug 28, 2024-$3.03-$1.50Beat
Apr 25, 2024-$3.25-$1.50Beat
Aug 29, 2023-$0.03-$0.90Miss

Analyst view

Consensus price target
$57.00 ▲ +228.0%
Range $44.00 – $70.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on PRTC and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.